MIROGAB TABLETS 5MG
MIROGABLIN BESYLATE
What it does
Mirogablin is a medication used to help manage nerve pain.
Commonly used for: nerve pain (neuropathic pain)
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-07-16 02:01:55 · updated 2026-10-20 02:06:35
About this medicine
Mirogablin is a medication used to help manage nerve pain.
What it treats
- nerve pain (neuropathic pain)
How it works
Mirogablin works by affecting certain signals in the brain and nerves to reduce pain.
Who it's for
This medication is for adults experiencing nerve pain.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: mirogablin
Mirogabine is an investigational compound that acts as a selective modulator of the M1 muscarinic acetylcholine receptor. It is primarily being studied for its potential use in treating conditions such as neuropathic pain and other pain-related disorders. Its pharmacological profile suggests that it may influence the endogenous pain pathways, offering a novel approach in pain management.
Indications
- Neuropathic pain
- Chronic pain syndromes
- Pain management in various clinical settings
Dosage
Children: Refer to clinical guidelines or consult a healthcare professional for appropriate dosing.
Adults: Refer to clinical guidelines or consult a healthcare professional for appropriate dosing.
Mechanism of action
Mirogabine selectively binds to and modulates the activity of the M1 muscarinic acetylcholine receptor, which is implicated in various central nervous system functions, including modulation of pain. By enhancing cholinergic signaling through this receptor, mirogabine may alter the perception of pain and contribute to analgesic effects.
Pharmacodynamics
Mirogabine's pharmacodynamics involve its interaction with the muscarinic acetylcholine receptors, particularly the M1 subtype, leading to changes in neurotransmitter release and synaptic plasticity. This activity can result in alterations in pain signaling pathways, potentially improving pain management by affecting both peripheral and central mechanisms of nociception.
Pharmacokinetics
The pharmacokinetic profile of mirogabine is not fully established due to its investigational status, but it is anticipated to follow a pattern similar to other muscarinic receptor modulators. It is expected to have oral bioavailability, undergo hepatic metabolism, and be excreted primarily through renal pathways. Further studies will clarify its absorption, distribution, metabolism, and excretion (ADME) characteristics.
Adverse effects
- Dizziness
- Somnolence
- Nausea
- Fatigue
- Dry mouth
Precautions
- Caution in patients with a history of substance abuse
- Monitor for signs of misuse or dependence
- Avoid abrupt discontinuation to prevent withdrawal symptoms
Pregnancy
Limited data available, use only if clearly needed and benefits outweigh risks.
Breast-feeding
Unknown if excreted in human milk, caution advised.
Storage
Store at room temperature, away from light and moisture.
Formulations
- Oral tablets
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.